3 Stocks Pushing The Health Services Industry Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 91 points (-0.5%) at 16,894 as of Thursday, July 10, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 864 issues advancing vs. 2,123 declining with 163 unchanged.

The Health Services industry currently sits down 0.7% versus the S&P 500, which is down 0.4%. On the negative front, top decliners within the industry include Mettler-Toledo International ( MTD), down 1.1%, St Jude Medical ( STJ), down 0.9%, Intuitive Surgical ( ISRG), down 0.9%, Agilent Technologies ( A), down 0.8% and UnitedHealth Group ( UNH), down 0.8%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Waters ( WAT) is one of the companies pushing the Health Services industry lower today. As of noon trading, Waters is down $1.04 (-1.0%) to $102.49 on light volume. Thus far, 104,738 shares of Waters exchanged hands as compared to its average daily volume of 607,800 shares. The stock has ranged in price between $101.41-$102.63 after having opened the day at $102.01 as compared to the previous trading day's close of $103.53.

Waters Corporation operates as an analytical instrument manufacturer in the United States and internationally. Waters has a market cap of $8.8 billion and is part of the health care sector. Shares are up 3.5% year-to-date as of the close of trading on Wednesday. Currently there are 4 analysts that rate Waters a buy, no analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates Waters as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Waters Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Universal Health Services ( UHS) is down $1.01 (-1.1%) to $92.72 on average volume. Thus far, 309,755 shares of Universal Health Services exchanged hands as compared to its average daily volume of 737,500 shares. The stock has ranged in price between $91.73-$92.87 after having opened the day at $92.57 as compared to the previous trading day's close of $93.73.

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. Universal Health Services has a market cap of $8.5 billion and is part of the health care sector. Shares are up 15.3% year-to-date as of the close of trading on Wednesday. Currently there are 11 analysts that rate Universal Health Services a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates Universal Health Services as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and compelling growth in net income. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Universal Health Services Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Becton Dickinson ( BDX) is down $0.64 (-0.5%) to $118.83 on average volume. Thus far, 369,308 shares of Becton Dickinson exchanged hands as compared to its average daily volume of 743,300 shares. The stock has ranged in price between $118.03-$118.93 after having opened the day at $118.16 as compared to the previous trading day's close of $119.47.

Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. Becton Dickinson has a market cap of $23.1 billion and is part of the health care sector. Shares are up 8.1% year-to-date as of the close of trading on Wednesday. Currently there are 6 analysts that rate Becton Dickinson a buy, 2 analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates Becton Dickinson as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, expanding profit margins, good cash flow from operations and increase in net income. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Becton Dickinson Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Starbucks Surprises With U.S. Sales Up 2%

Starbucks Surprises With U.S. Sales Up 2%

Dow Jumps 238 Points as S&P 500, Nasdaq Also Climb

Dow Jumps 238 Points as S&P 500, Nasdaq Also Climb

Why Nashville, Denver, LA Should Reconsider Bids for Amazon HQ2

Why Nashville, Denver, LA Should Reconsider Bids for Amazon HQ2

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists

Jim Cramer: Visa Is a Technology Company That Masquerades as a Financial Company

Jim Cramer: Visa Is a Technology Company That Masquerades as a Financial Company